Article Information
History
- December 4, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Stefanie Kalfas, MD1,
- Kumar Visvanathan, MBBS FRACP PhD2,3,
- Kim Chan, DSc PhD4 and
- John Drago, MBBS FRACP PhD1,5,*
- 1Florey Institute of Neuroscience and Mental Health, University of Melbourne, VIC, Australia
- 2Department of infectious Diseases, St. Vincent’s Hospital, Melbourne, VIC, Australia
- 3Department of Medicine, Dentistry and Health Sciences, University of Melbourne, VIC, Australia
- 4Sydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, NSW, Australia
- 5Department of Neurology, St. Vincent’s Hospital, Melbourne, VIC, Australia
- ↵*corresponding author: john.drago{at}florey.edu.au
Posted December 04, 2020.
THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A SYSTEMATIC REVIEW OF MECHANISMS AND EVIDENCE
